Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Sirtuin Biology in Cancer and Metabolic Disease

Cellular Pathways for Clinical Discovery

Kenneth Maiese (Herausgeber)

Buch | Softcover
300 Seiten
2021
Academic Press Inc (Verlag)
978-0-12-822467-0 (ISBN)
CHF 219,95 inkl. MwSt
Sirtuin Biology in Cancer and Metabolic Disease: Cellular Pathways for Clinical Discovery offers a compelling and thought-provoking perspective for the examination of the intriguing biology of sirtuins that ties cancer and metabolic disease together and provides a critical platform for the development of sirtuin-based novel therapeutic strategies to effectively treat cancer and metabolic disorders with precision in order to minimize any potentially detrimental clinical outcomes. An exciting prospect for the development of innovative therapeutics for cancer and metabolic disorders involves sirtuins. Sirtuins are histone deacetylases that have an intricate role in the onset and development of cancer and metabolic disease. Implementing a translational medicine format, this innovative reference highlights the ability of sirtuins to oversee critical pathways that involve stem cell maintenance, cellular proliferation, metabolic homeostasis, apoptosis, and autophagy that can impact cellular dysfunction and unchecked cellular growth that can occur during cancer and metabolic disease. Each chapter offers an intuitive perspective of advances on the application of sirtuin pathways for cancer and metabolic disease that will be become a "go-to" resource for a broad audience of scientists, physicians, pharmaceutical industry experts, nutritionists, and students.

Kenneth Maiese, MD, is an internationally recognized physician-scientist whose investigations are designed to translate basic science into successful therapeutic treatments. He maintains therapeutic and scientific expertise in multiple medical disciplines and has been fortunate to receive recognition with outstanding teaching and investigator awards, election to America’s Top Physicians and The Best of U.S. Physicians, recipient of Albert Nelson Marquis Lifetime Achievement Award, and elected as an America’s Health Insurance Plans (AHIP) Executive Leadership Fellow. His work has received the distinction of “High Impact Research and Potential Public Health Benefit” by the National Institutes of Health. As an internationally recognized physician researcher and “C-suite” healthcare leader, he has extensive experience in academic medicine, healthcare delivery, business development, managed care, biotechnology, and drug development holding positions as member and advisor for the National Institutes of Health Biotechnology and Venture Capital Development, National Institutes of Health Innovation Network, Chief Medical Officer, tenured Professor and Chair and Chief of Service of the Department of Neurology and Neurosciences of Rutgers University, Global Head of Translational Medicine and External Innovation, Board Member of the Cancer Institute of New Jersey, Steering Committee Member for the Foundation for the National Institutes of Health, tenured Professor in Neurology, Anatomy & Cell Biology, Molecular Medicine, the Barbara Ann Karmanos Cancer Institute, and the National Institute of Health Center at Wayne State University, and Founding Editor and Editor-in-Chief of multiple highly successful international journals.

Preface

Section I: Sirtuins and metabolic disease
1. Sirtuins in metabolic disease: innovative therapeutic strategies with SIRT1, AMPK, mTOR, and nicotinamide
Kenneth Maiese
2. Sirtuins in metabolic and epigenetic regulation of stem cells
Yi Fang and Xiaoling Li
3. Sirtuins and metabolic regulation: food and supplementation
Sérgio Henrique Sousa Santos, Victor Hugo Dantas Guimarães, Janaina Ribeiro Oliveira, and Luiz Fernando Rezende
4. Sirtuins in diabetes mellitus and diabetic kidney disease
Kultigin Turkmen
5. Sirtuins and mitochondrial dysfunction
Jian-Li He, Tian-Shi Wang, and Yi-Ping Wang
6. Sirtuins in immunometabolism
Hongxiu Yu
7. Mitochondrial sirtuins at the crossroads of energy metabolism and oncogenic transformation
Maja Grabacka and Przemyslaw M. Plonka

Section II: Sirtuins and cancer
8. Sirtuins and the hallmarks of cancer
Talita H.B. Gomig, Tayana S. Jucoski, Erika P. Zambalde, Alexandre L.K. Azevedo, Daniela F. Gradia, and Enilze M.S.F. Ribeiro
9. The bifunctional roles of sirtuins and their therapeutic potential in cancer
Yeuan Ting Lee, Yi Jer Tan, Pei Yi Mok, Ayappav. Subramaniam, and Chern Ein Oon
10. Sirtuins and next generation hallmarks of cancer: cellular energetics and tumor promoting inflammation
Robert Kleszcz and Wanda Baer-Dubowska
11. Sirtuins and cellular metabolism in cancers
Zhen Dong and Hongjuan Cui
12. Dual role of sirtuins in cancer
Margalida Torrens-Mas and Pilar Roca
13. Sirtuin signaling in hematologic malignancies
Ryan A. Denu
14. Impacts of sirtuin1 and sirtuin3 on oral carcinogenesis
Shajedul Islam, Yoshihiro Abiko, Osamu Uehara, Yasuhiro Kuramitsu, and Itsuo Chiba
Index

Erscheinungsdatum
Verlagsort San Diego
Sprache englisch
Maße 216 x 276 mm
Gewicht 860 g
Themenwelt Medizinische Fachgebiete Innere Medizin Diabetologie
ISBN-10 0-12-822467-3 / 0128224673
ISBN-13 978-0-12-822467-0 / 9780128224670
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Norbert Suttorp; Martin Möckel; Britta Siegmund …

Buch | Softcover (2017)
ABW Wissenschaftsverlagsgesellschaft
CHF 79,95